Angiopoietin-4 increases permeability of blood vessels and promotes lymphatic dilation

FASEB Journal

Volumn 29, Issue 9, 2015, Pages 3668-3677

  Kesler, Cristina T ^a   Pereira, Ethel R ^a   Cui, Cheryl H ^a   Nelson, Gregory M ^b   Masuck, David J ^a   Baish, James W ^c   Padera, Timothy P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c BUCKNELL UNIVERSITY   (United States)

Author keywords

2 photon microscopy; Endothelial; Lymphangiography; TIE2

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN 4; ANGIOPOIETIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN C; ANGPT4 PROTEIN, MOUSE; MAPK1 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL GROWTH FACTOR C, MOUSE; VEGFC PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FEMALE; FIBROSARCOMA; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPH NODE METASTASIS; LYMPH VESSEL; MULTIPHOTON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASODILATATION; ANIMAL; CAPILLARY PERMEABILITY; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY;

ANGIOPOIETINS; ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; FIBROSARCOMA; HUMANS; LYMPHATIC VESSELS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84942869441     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-268920     Document Type: Article

References (39)

1. Kim, K. T., and Choi, H. H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H. Z., Lee, G. M., and Koh, G. Y. (2005) Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J. Biol. Chem. 280, 20126-20131
2. Augustin, H. G., and Koh, G. Y., Thurston, G., and Alitalo, K. (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10, 165-177
3. Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., Olsen, B. R., and Alitalo, K. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cellmatrix contacts. Nat. Cell Biol. 10, 527-537
4. Fukuhara, S., Sako, K., Minami, T., Noda, K., and Kim, H. Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G. Y., and Mochizuki, N. (2008) Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat. Cell Biol. 10, 513-526
5. Gavard, J., Patel, V., and Gutkind, J. S. (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell 14, 25-36
6. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N., Yancopoulos, G. D., and Yancopoulos, G. D. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disruptsin vivo angiogenesis. Science 277, 55-60
7. Bogdanovic, E., and Nguyen, V. P., and Dumont, D. J. (2006) Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J. Cell Sci. 119, 3551-3560
8. Lobov, I. B., and Brooks, P. C., and Lang, R. A. (2002) Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl. Acad. Sci. USA 99, 11205-11210
9. Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., Suri, C., Campochiaro, P. A., Wiegand, S. J., and Yancopoulos, G. D. (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell 3, 411-423
10. Valenzuela, D. M., and Griffiths, J. A., Rojas, J., Aldrich, T. H., Jones, P. F., Zhou, H., McClain, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Huang, T., Papadopoulos, N., Maisonpierre, P. C., Davis, S., and Yancopoulos, G. D. (1999) Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA 96, 1904-1909
11. Lee, H. J., and Cho, C. H., Hwang, S. J., Choi, H. H., Kim, K. T., Ahn, S. Y., Kim, J. H., Oh, J. L., Lee, G. M., and Koh, G. Y. (2004) Biological characterization of angiopoietin-3 and angiopoietin-4. FASEB J. 18, 1200-1208
12. Lund, E. L., Høg, A., Olsen, M. W., Hansen, L. T., Engelholm, S. A., and Kristjansen, P. E. (2004) Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma. Int. J. Cancer 108, 833-838
13. Yamakawa, M., and Liu, L. X., Date, T., Belanger, A. J., Vincent, K. A., Akita, G. Y., Kuriyama, T., Cheng, S. H., Gregory, R. J., and Jiang, C. (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ. Res. 93, 664-673
14. Olsen, M. W. B., and Ley, C. D., Junker, N., Hansen, A. J., Lund, E. L., and Kristjansen, P. E. (2006) Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure. Neoplasia 8, 364-372
15. Kim, K. E., and Cho, C. H., Kim, H. Z., Baluk, P., McDonald, D. M., and Koh, G. Y. (2007) In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin. Arterioscler. Thromb. Vasc. Biol. 27, 564-570
16. Leunig, M., and Goetz, A. E., Dellian, M., Zetterer, G., Gamarra, F., and Jain, R. K., and Messmer, K. (1992) Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. Cancer Res. 52, 487-490
17. Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y. L., Pytowski, B., Fukumura, D., Padera, T. P., and Jain, R. K. (2006) Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res. 66, 8065-8075
18. Goel, S., Gupta, N., Walcott, B. P., Snuderl, M., Kesler, C. T., Kirkpatrick, N. D., Heishi, T., Huang, Y., Martin, J. D., Ager, E., Samuel, R., Wang, S., Yazbek, J., Vakoc, B. J., Peterson, R. T., Padera, T. P., Duda, D. G., Fukumura, D., and Jain, R. K. (2013) Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. J. Natl. Cancer Inst. 105, 1188-1201
19. Chae, S. S., and Kamoun, W. S., Farrar, C. T., Kirkpatrick, N. D., Niemeyer, E., de Graaf, A. M., Sorensen, A. G., Munn, L. L., Jain, R. K., and Fukumura, D. (2010) Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. Clin. Cancer Res. 16, 3618-3627
20. Kadambi, A., Mouta Carreira, C., Yun, C. O., Padera, T. P., Dolmans, D. E., Carmeliet, P., Fukumura, D., and Jain, R. K. (2001) Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res. 61, 2404-2408
21. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., and Detmar, M. (2001) Induction of tumor lymphangiogenesis by VEGF-Cpromotes breast cancer metastasis. Nat. Med. 7, 192-198
22. Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., Munn, L. L., and Jain, R. K. (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296, 1883-1886
23. Karnezis, T., Shayan, R., Caesar, C., Roufail, S., and Harris, N. C., Ardipradja, K., Zhang, Y. F., Williams, S. P., Farnsworth, R. H., Chai, M. G., Rupasinghe, T.W., Tull, D.L., Baldwin, M.E., Sloan, E.K., Fox, S. B., Achen, M. G., and Stacker, S. A. (2012) VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21, 181-195
24. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D. G., Orci, L., Alitalo, K., Christofori, G., and Pepper, M. S. (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672-682
25. Karpanen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Ylä-Herttuala, S., Jäättelä, M., and Alitalo, K. (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61, 1786-1790
26. Wong, S. Y., Haack, H., Crowley, D., Barry, M., and Bronson, R. T., and Hynes, R. O. (2005) Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res. 65, 9789-9798
27. Achen, M. G., and Williams, R. A., Minekus, M. P., Thornton, G. E., Stenvers, K., Rogers, P. A., Lederman, F., Roufail, S., and Stacker, S. A. (2001) Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J. Pathol. 193, 147-154
28. Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S., Kubo, H., and Achen, M. G. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7, 186-191
29. Carlson, T. R., Feng, Y., Maisonpierre, P. C., Mrksich, M., and Morla, A. O. (2001) Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276, 26516-26525
30. Thomas, M., Felcht, M., Kruse, K., Kretschmer, S., Deppermann, C., Biesdorf, A., Rohr, K., Benest, A. V., Fiedler, U., and Augustin, H. G. (2010) Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation. J. Biol. Chem. 285, 23842-23849
31. Padera, T. P., and Stoll, B. R., So, P. T., and Jain, R. K. (2002) Conventional and high-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions. Mol. Imaging 1, 9-15
32. Peters, S., Cree, I.A., Alexander, R., Turowski, P., Ockrim, Z., Patel, J., Boyd, S. R., Joussen, A. M., Ziemssen, F., Hykin, P. G., and Moss, S. E. (2007) Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability. Cytokine 40, 144-150
33. Yao, L.C., Baluk, P., Srinivasan, R.S., Oliver, G., and Mc Donald, D.M. (2012) Plasticity of button-like junctions in the endothelium of airway lymphaticsin development and inflammation. Am. J. Pathol. 180, 2561-2575
34. Gavrilovskaya, I. N., and Gorbunova, E. E., and Mackow, E. R. (2013) Hypoxia induces permeability and giant cell responses of ANDV infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway. J. Virol. 87, 12999-13008
35. Huang, H., Bhat, A., Woodnutt, G., and Lappe, R. (2010) Targeting the ANGPT-TIE2 pathway in malignancy. Nat. Rev. Cancer 10, 575-585
36. Andersen, S., Donnem, T., Al-Shibli, K., Al-Saad, S., Stenvold, H., Busund, L. T., and Bremnes, R. M. (2011) Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2. PLoS ONE 6, e19773
37. Lyu, T., Jia, N., Wang, J., Yan, X., Yu, Y., Lu, Z., Bast, R.C., Jr., Hua, K., and Feng, W. (2013) Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma. Epigenetics 8, 1330-1346
38. Currie, M.J., Gunningham, S.P., Han, C., Scott, P.A., Robinson, B.A., Harris, A. L., and Fox, S. B. (2001) Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Clin. Cancer Res. 7, 918-927
39. Brunckhorst, M. K., Wang, H., Lu, R., and Yu, Q. (2010) Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis. Cancer Res. 70, 7283-7293